Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Managing Diabetes & CVD: Is epigenetics a new way forward?

Rservlogix large

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Toinv

Toinv

Rank: President [?]

Points: 4445 [?]

Votes: 35 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Managing Diabetes & CVD: Is epigenetics a new way forward?

in response to

Re: Managing Diabetes & CVD: Is epigenetics a new way forward?

by

posted on Jun 23, 2017 11:32AM

Log in to use the IP Check tool ^[?]

Bear

August 27 moderated poster (speaker Daisuke SHISHIKURA from Adelaide, Australia) "The effect of apabetalone on attenuated coronary atherosclerotic plaque: insights from the ASSURE trial."

----------

That is a name I have not heard before. Might it imply that more independent researchers are exploring apabetalone?

Regards

Toinv

Loading...

Loading...

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Share

Share

Share

Please to post a reply